MorphoSys seizes FOMC glee to get €84m and zero discount
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Equity

MorphoSys seizes FOMC glee to get €84m and zero discount

German biotechnology firm MorphoSys raised €84m through a sale of new shares on Wednesday night. Pre-sounding gave bankers the confidence to launch the deal before any statements from Wednesday's Federal Open Market Committee meetings in the US, but the positive market reaction to the news later that the Fed was not looking to reduce its bond-buying programme immediately helped the deal to price with no discount.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article